VG101（Bionovo）

N/A

Report date: 2023/05/17 20:00:39

Base Information

Drug NameVG101（Bionovo）
Drug Alias NameVG101VG-101
ClassificationNatural product/Extract
Mechanisms of ActionEstrogen receptor beta agonists
TargetsEstrogen receptor beta
Therapy Area/IndicationsVulvar and vaginal atrophyAtrophic Vaginitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBionovo Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBionovo Inc
Active IndicationsN/A
Inactive IndicationsVulvar and vaginal atrophyAtrophic Vaginitis

Other Information

ATC CodeN/A
Related LinksN/A